ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT05765084 updates: 1. completion date: 2026-10-01 → 2027-10-01 2. primary completion date: 2026-10-01 → 2027-10-01
Clinical trial NCT05765084 updates: 1. completion date: 2026-10-01 → 2027-10-01 2. primary completion date: 2026-10-01 → 2027-10-01
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical